Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Toronto Stock Exchange  >  Bausch Health Companies Inc    BHC   CA0717341071

BAUSCH HEALTH COMPANIES INC (BHC)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweetsMarketScreener Strategies

Bausch Health : Up Over 12%, on Pace for Largest Percent Increase Since Nov 2017 -- Data Talk

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/12/2018 | 05:45pm CET

Bausch Health Companies Inc. (BHC) is currently at $23.25, up $2.58 or 12.48%.

-- Would be highest close since Aug. 30, 2018, when it closed at $23.60

-- On pace for largest percent increase since Nov. 7, 2017, when it rose 17.11%

-- Earlier Wednesday, Bausch Health along with its wholly owned subsidiary, Salix Pharmaceuticals, said it has reached an agreement in a patent dispute over 550 mg tablets of Xifaxan

-- Up 11.89% year-to-date

-- Up 64.78% from 52 weeks ago (Sept. 13, 2017), when it closed at $14.11

-- Up 110.22% from its 52-week closing low of $11.06 on Nov. 2, 2017

-- Traded as high as $24.10; highest intraday level since Aug. 8, 2018, when it hit $24.30

-- Up 16.59% at today's intraday high; largest intraday percent increase since May 8, 2018, when it rose as much as 17.18%

All data as of 11:16:34 AM

Source: Dow Jones Market Data, FactSet

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAUSCH HEALTH COMPANIES IN
04:38pBAUSCH HEALTH : expands contact lens manufacturing facilities in Co Waterford
AQ
11/15BAUSCH HEALTH : + Lomb Reports More Than Five Million Units Of Contact Lens Mate..
AQ
11/15BAUSCH HEALTH : + Lomb to expand manufacturing in Rochester, Ireland
AQ
11/14BAUSCH HEALTH : + Lomb Waterford expansion to result in 100 new jobs
AQ
11/13BAUSCH HEALTH : Will Expand Contact Lens Manufacturing Facilities In Rochester, ..
PR
11/07BAUSCH HEALTH COMPANIES INC. : Regulation FD Disclosure, Other Events, Financial..
AQ
11/07BAUSCH HEALTH : Commences Cash Tender Offer And Consent Solicitation For Any And..
PR
11/07BAUSCH HEALTH : To Seek Incremental Amendment To Its Existing Credit Agreement
PR
11/07BAUSCH HEALTH : + Lomb to Present New Scientific Data During the American Academ..
AQ
11/07BAUSCH HEALTH : To Participate At The Stifel 2018 Healthcare Conference
PR
More news
News from SeekingAlpha
11/14BIOTECH BIO SERIES #4 : Regeneron Is Not Done 
11/13Express Scripts launches new formulary aimed at reducing drug costs 
11/09The Finishing Stretch For Several Ideas 
11/08BAUSCH HEALTH COMPANIES : Shareholder Dilution Happening? 
11/08Bausch Health to refinance certain debt 
Financials ($)
Sales 2018 8 522 M
EBIT 2018 3 189 M
Net income 2018 -3 342 M
Debt 2018 23 754 M
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales 2018 3,84x
EV / Sales 2019 3,70x
Capitalization 8 939 M
Chart BAUSCH HEALTH COMPANIES INC
Duration : Period :
Bausch Health Companies Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAUSCH HEALTH COMPANIES IN
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Average target price 18,2 $
Spread / Average Target -29%
EPS Revisions
Managers
NameTitle
Joseph C. Papa Chairman & Chief Executive Officer
Paul S. Herendeen Chief Financial Officer & Executive Vice President
Jerzy Janeczko Head-Information Technology
Tage Ramakrishna Chief Medical Officer, President-R&D
Robert N. Power Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BAUSCH HEALTH COMPANIES INC29.12%8 939
JOHNSON & JOHNSON3.24%387 546
PFIZER18.47%250 618
NOVARTIS6.19%221 937
ROCHE HOLDING LTD.0.39%212 046
MERCK AND COMPANY33.00%194 612